Assessment of Liver Graft Steatosis: Where Do We Stand?

Liver Transpl. 2019 Mar;25(3):500-509. doi: 10.1002/lt.25379.

Abstract

The growing number of patients on waiting lists for liver transplantation and the shortage of organs have forced many centers to adopt extended criteria for graft selection, moving the limit of acceptance for marginal livers. Steatotic grafts that were, in the past, considered strictly unacceptable for transplantation because of the high risk of early nonfunction are now considered as a potential resource for organ implementation. Several methods to diagnose, measure, classify, and stage steatosis exist, but none can be considered qualitatively and quantitatively "the ideal method" to date. Clinical, biological, and imaging data can be very helpful to estimate graft steatosis, but histology still remains the gold standard. There is an increasing need for rapid and reliable tools to assess graft steatosis. Herein, we present a comprehensive review of the approaches that are currently used to quantify steatosis in liver grafts.

Publication types

  • Review

MeSH terms

  • Allografts / diagnostic imaging
  • Allografts / pathology
  • Allografts / supply & distribution
  • Donor Selection / methods*
  • Donor Selection / standards
  • End Stage Liver Disease / surgery*
  • Fatty Liver / blood
  • Fatty Liver / diagnosis*
  • Fatty Liver / pathology
  • Humans
  • Liver / diagnostic imaging
  • Liver / pathology
  • Liver Function Tests
  • Liver Transplantation / standards*
  • Magnetic Resonance Imaging
  • Severity of Illness Index
  • Tomography, X-Ray Computed
  • Ultrasonography